Particle Health says data dispute with Epic Systems not affecting most customers

Particle Health says data dispute with Epic Systems not affecting most customers


Joos Mind | Photodisc | Getty Images

Particle Health said on Monday that the “vast majority” of its customers are still receiving records from medical software giant Epic Systems despite an ongoing dispute between the two companies over data-sharing practices.

Epic’s software supports more than 300 million patient records, and Particle acts like a middleman that helps health-care organizations access the data they need. Both companies belong to an interoperability network called Carequality, which facilitates the exchange of patient information on a large scale.

On March 21, Epic filed a formal dispute with Carequality citing concerns that Particle and its participant organizations “might be inaccurately representing the purpose associated with their record retrievals.” In order to join the Carequality network, organizations are approved and must abide by “Permitted Purposes,” generally having to do with treatment, for the exchange of patient records

Patient data is protected by a federal law called the Health Insurance Portability and Accountability Act, or HIPAA, which requires a patient’s consent or knowledge for third-party access.

Particle said in a release Monday that while Epic “indiscriminately stopped responding” to data requests from some of its customers because of the dispute, most clients were not affected. The company said it’s been pressing Epic to restore connection to impacted customers, and many are already back to normal.

“While there is an ongoing dispute between Epic and Particle Health, related to three specific customers, the significant majority of Particle Health customers impacted by Epic’s actions were not in any way related to this dispute,” the company said in the release.

Particle CEO Jason Prestinario said in the statement that the company will address the dispute with Epic through official procedural channels.

Epic did not immediately respond to CNBC’s request for comment.

WATCH: Insurer stocks fall on Medicare rates

Health care stocks headed for worst day since early November



Source

Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
Health

Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers

U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC. Win Mcnamee | Getty Images President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not […]

Read More
Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug
Health

Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug

Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer‘s newest bet on obesity is already showing promise.  The company last week said it would buy […]

Read More
Trump, Pfizer to announce agreement to lower Medicaid drug prices
Health

Trump, Pfizer to announce agreement to lower Medicaid drug prices

U.S. President Donald Trump speaks during a press conference in the Roosevelt Room at the White House in Washington, D.C., U.S., May 12, 2025. Nathan Howard | Reuters President Donald Trump on Tuesday will announce an agreement with Pfizer to voluntarily sell its medications for less, as his administration pushes to link U.S. drug prices […]

Read More